Novel substituted quinazolines for potent EGFR tyrosine kinase inhibitors

Article

Abstract: The type I receptor tyrosine kinases (RTKs) are involved in various aspects of cell growth, survival

Palabras claves:

Antitumour, Bioisostere, eGFR, Erlotinib, Gefitinib, HER-2, Quinazoline, Tyrosine kinase inhibitor

Autores:

Campos J.M., Conejo-García A., Cruz-López O., Fátima Morales, García-Rubino M.E., Gómez-Pérez V., Kimatrai M., Núnez M.C.

Fuentes:

scopus